You are using an outdated browser.

2 Attractive Biotech Stocks Under $10 For Spring | Seeking Alpha

Please upgrade your browser to improve your experience. That makes low-priced stocks poor choices for the risk-averse but a fun gamble for investors who have some cash to burn.

Share prices and related figures are as of March Price-earnings ratios are based on estimated profits for the next four quarters.

Sales are for the last four quarters.

By Kathy Kristof , Contributing Editor March Since then the shares have bounced around, but they remain far below the heights they reached in those heady early days. However, the market for radiation-therapy machines is growing rapidly worldwide, and Accuray is zeroing in on those emerging international markets, says Benjamin Nahum, comanager of the Neuberger Berman Intrinsic Value Fund NINAX.

These 5 Stocks Under $10 Could Ignite Soon - TheStreet

Nahum thinks the company will eventually turn profitable. He adds that a bigger company might want to acquire Accuray for its technology.

Since the company announced a restructuring plan in , losses have piled up and the stock price has plummeted.

In the six-month period that ended December 31, sales fell 3. Arden has been replacing top managers in both its cosmetics and fragrance lines, and it is revamping its product lines and cutting costs.

But after peaking in the s, the brand lost its luster, and the stock price has been languishing ever since. After the sale, Callaway will still retain a Callaway generates about half of its sales overseas, so it has been swinging against currency headwinds, Burns adds. The company now plans to get out of the printed book business in favor of an all-digital portfolio.

Analysts also expect it to be good for the stock. Raymond James analyst Wayne Johnson expects rapid growth over the next few years as a growing number of card issuers upgrade to more-secure technology. The company, which provides movies, television shows, music, games and Wi-Fi on some airplanes worldwide, has been striking new deals and expanding its services at a rapid clip.

Global Eagle makes money in several ways: As consumers become increasingly wired to the Web, Global Eagle expects demand for its gate-to-gate Wi-Fi services to mount.

Revenues have yet to translate into profits for the five-year-old enterprise, but losses are ebbing, and analysts believe will be the year Global Eagle turns profitable. And they expect profits to quadruple in If the drug proves as safe and effective as analysts expect, it could win Food and Drug Administration approval for use in Enhanze, a Halozyme drug that is already on the market, delivers cancer treatments via injections under the skin, rather than with pills.

Halozyme has yet to post a full-year profit and is likely to continue losing money indefinitely. Biotechnology companies are increasingly looking for ways to help the body heal itself. In January, the company bought Stability Biologics, which makes products for bone and tissue grafts for burns and traumatic wound care.

Given the expected growth, the stock, at 26 times projected earnings, looks well-priced.

View as One Page. Toggle navigation Menu Subscribers Log In. Sections Close Menu Wealth Creation Investing Retirement Taxes Your Money Your Business Magazine Contents.

See All Marketplace Special Reports Tools Slide Shows Quizzes Videos Columns Basics of Personal Finance Economic Outlooks. Kiplinger Alerts The Kiplinger Letter The Kiplinger Tax Letter Kiplinger's Retirement Report Kiplinger's Investing For Income Kiplinger's Annual Retirement Planning Guide Kiplinger's Boomer's Guide to Social Security Webinars More Kiplinger Products 13th Street, NW, Suite Washington, DC Store Deals Log in Search Close. Toggle navigation Menu Subscribers.

Store Deals Log in. Find Hot Deals in Kiplinger's New Marketplace. SLIDE SHOW Best Index Funds for Every Investor. QUIZ Will It Sink Your Credit Score?

SLIDE SHOW Best Credit Unions Anyone Can Join, Slide Show 1 of 9. Slide Show 2 of 9. Slide Show 3 of 9. Slide Show 4 of 9. Slide Show 5 of 9. Slide Show 6 of 9. Slide Show 7 of 9. Slide Show 8 of 9. Slide Show Start Over Next Slide Show 7 Stocks to Own in a Volatile Market. Check Out Kiplinger's Latest Online Broker Rankings googletag. About Us Employment Opportunities Privacy Policy Terms of Service Millennium Copyright Act Site Map RSS.